RE-SOLVE

Welcome to the Brand page for “RE-SOLVE”, which is offered here for Resolve;conducting clinical trials of pharmaceutical products directed to the treatment and prevention of thrombosis;.

Its status is currently believed to be active. Its class is unavailable. “RE-SOLVE” is believed to be currently owned by “Boehringer Ingelheim International GmbH”.


Owner:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Owner Details
Description:
RESOLVE;Conducting clinical trials of pharmaceutical products directed to the treatment and prevention of thrombosis;
Categories: RESOLVE